je.st
news
Bayer clotting drug meets late-stage study's goal
2014-02-19 06:09:20| Biotech - Topix.net
The medicine, called BAY 94-9027, helped prevent damaging internal bleeding in patients when given less frequently than standard treatments, which many patients need every other day.
Tags: goal
drug
meets
bayer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||